Global Packaging and Labeling CDMO Market Analysis by Size, Share, Growth, Trends, Developments & Forecasts by 2027

Contract Development and Manufacturing Organizations (CDMOs) specializing in packaging encompass a broad range of services, which includes product development, clinical and commercial API production, the manufacturing of medication products, primary and secondary packaging, labeling, sterilization, and distribution. They further provide customized packaging solutions to manufacturers for some complex or specific products.

Growing Demand for Environment Friendly Packaging and Labeling, and Compliance with Regulatory Needs are the Major Factors Fueling the Packaging and Labeling CDMO Market Growth

The global packaging and labeling CDMO market is a fast growing market. In recent years, CDMOs have witnessed various transformations in their packaging and labeling practices, reflecting a multifaceted evolution within the market. Primarily, sustainability has emerged as a dominant factor, with a focus on environmentally friendly packaging and labeling solutions. 

Further, in markets such as pharmaceutical and healthcare, strict regulations have increased the demand for serialization and track-and-trace solutions. CDMOs are implementing advanced technologies such as QR codes, RFID, etc. to assure in adherence to the regulatory needs, improve transparency within the supply chain, and combat counterfeiting. Security features, such as tamper-evident seals and holograms, are gaining popularity due to growing concerns on product tampering and counterfeiting.

Key Growth Drivers of Packaging and Labeling CDMO Market

The global packaging and labeling CDMO market is estimated to experience a healthy CAGR during the forecast period. Filling and packaging play a very crucial role in the overall contract manufacturing process. The need for a specialty packaging service has given rise to an alternate industry of contract manufacturing. Most companies are outsourcing the packaging work to companies who are skilled in handling the packaging of drugs and devices. 

Growing elderly population, strict regulatory needs of governing agencies, and advanced packaging technologies are some of the major factors which will drive the growth of the global packaging and labeling CDMO market. Further, the shortage of in-house packaging capabilities, experts, and budget limitations for small firms is poised to speed up the worldwide market’s growth.

For instance,

  • In June 2023, Catalent announced that its OneBio® Suite, an integrated solution encompassing development, manufacturing, and supply, has been expanded to encompass various biologic modalities. This suite offers customers with an all-inclusive service designed to expedite the progression of programs from development to manufacturing. This includes activities such as fill or finish, packaging, and assistance with clinical supply and commercial launch.

North America Holds the Largest Market Share in the Packaging and Labeling CDMO Market 

North America holds the largest market share in the packaging and labeling CDMO market. This can be mainly attributed to the growing elderly population, robust R&D activities, and the presence of leading market players in the region. However, the Asia-Pacific region is set to witness the highest CAGR in the forecast period. Other major factors such as technological innovations in packaging and growing investments in healthcare are driving the Asia-Pacific market.

Competitive Landscape Analysis: Packaging and Labeling CDMO Market

Some of the leading and emerging players operating in the global packaging and labeling CDMO market are Aphena Pharma Solutions, Eurofins Scientific, Catalent, PCI Pharma, Pfizer CentreOne, Becton, Dickinson & Co, Almac Group, Jabil, Tecomet, Integer.

The global packaging and labeling CDMO market is a rapidly growing market and is set to witness a healthy growth in the coming years due to a major focus on developing new drugs and devices, rising investments in the R&D activities to introduce many advanced products, and aggressive growth strategies adopted by the global market players.

Get a FREE Sample Report on Packaging and Labeling CDMO Market @ https://meditechinsights.com/packaging-and-labeling-cdmo-market/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Drug Discovery Software market valued at $2 billion in 2020, is projected to grow at a healthy CAGR of 14% to reach $3.5 billion by 2025

The global drug discovery software market (such as ligand-based design, structure-based design, LIMS, ELN) is driven by the increasing R&D spend and pipeline, expanding scope and scale, increasing stringency of testing and regulations, growing number and size of biotechs, need for increasing cost efficiencies and reducing time to market, and move towards web/cloud-based software. Global Drug Discovery Software Market – Niche but Fast-Growing Market The worldwide drug discovery software market is niche and growing rapidly, driven by the rising pressure on the pharma and biotech companies to cut costs in the research and preclinical stage of drug development, reduce timelines and improve transparency through deep learning software tools. “ Large players present in this segment are trying to consolidate the market by becoming a one stop shop. Moreover, companies are also considering to combine their solutions with bioinformatics and LIMS tools to have a competitive edge .” - Exe
Read more

Global Genomics Market Report Reveals Rapid Growth & Transformative Trends in the Genomic Industry by 2027

In the ever-evolving landscape of healthcare, genomics is making headlines for its groundbreaking contributions to personalized medicine, disease understanding, and advancements in pharmaceutical research. The Global Genomics Market Report for 2023 highlights the impressive growth and transformative trends within the genomics industry, shedding light on the exciting potential of genomics in shaping the future of healthcare. I. The Genomics Market Landscape The report's comprehensive analysis of the global genomics market reveals a dynamic and rapidly expanding landscape. With a CAGR of over [X]% during the forecast period, the industry is experiencing unprecedented growth. Key factors driving this growth include increased adoption of genomics in clinical diagnostics, expanding genomics research initiatives, and the development of advanced sequencing technologies. II. Personalized Medicine Revolution One of the most exciting trends highlighted in the report is the integration of ge
Read more